Piramal Pharma Solutions, a leading contract development and manufacturing organization (CDMO), today announced that the company will be partnering with Epirium Bio on an exclusive manufacturing relationship for new orphan drugs targeting rare diseases with high unmet needs. The Piramal Pharma Solutions (PPS) team is providing Epirium with an integrated program that encompasses formulation development, […]
